American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)
  7. GSK Faculty (1390)
  8. Population Sciences Research Program (1385)
  9. Gastrointestinal Oncology Service (1358)
  10. Hematologic Malignancies, Division of (1286)
Search Within
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2591)
  3. Editorial (82)
  4. Review (70)
  5. Guidelines (55)
  6. Correspondence (51)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6413)
  2. Solid Tumor Oncology Division (5551)
  3. Survivorship Research (2002)
  4. Genitourinary Oncology Service (1770)
  5. Surgery (1646)
  6. Epidemiology and Biostatistics (1500)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (310)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (308)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8715)
  2. JCO Precision Oncology (174)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (54)
  6. JCO Oncology Practice (13)

More Publications

Results (9200)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I study of everolimus (E) plus low-dose weekly cisplatin (C) for patients with advanced solid tumors
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Wu, N.; Haque, S.; Lisa, D. M.; Carlson, D.; Pfister, D. G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Susceptibility loci associated with prostate cancer progression and mortality
    Meeting Abstract

    Gallagher, D. J.; Joseph, V.; Cronin, A.; Vickers, A. J.; Reuter, V. E.; Scher, H. I.; Eastham, J.; Lilja, H.; Kirchhoff, T.; Offit, K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Surgical cytoreduction in patients with colorectal peritoneal carcinomatosis treated with contemporary chemotherapy
    Meeting Abstract

    Gava, V. G.; Reidy, D. L.; Paty, P.; Saltz, L.; Chung, K. Y.; Weiser, M. R.; Temple, L. K.; Segal, N. H.; Moreira, L. F.; Nash, G.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Positron emission tomography (PET) and estrogen receptor (ER) ligand in patients with invasive breast cancer
    Meeting Abstract

    Gemignani, M.; Patil, S.; Brogi, E.; Larson, S. M.; Morrow, M.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Immunologic response to xenogeneic gp100 DNA in melanoma patients: Comparison of particle-mediated epidermal delivery with intramuscular injection
    Meeting Abstract

    Ginsberg, B. A.; Wolchok, J. D.; Roman, R.; Gallardo, H. F.; Chapman, P. B.; Schwartz, G. K.; Carvajal, R. D.; Terzulli, S. L.; Bewkes, B. B.; Yuan, J. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Financial and psychosocial impacts of adjuvant chemotherapy in older colorectal cancer patients
    Meeting Abstract

    Elkin, E. B.; Hamilton, A. A.; Patel, S.; Temple, L. K.; Stevenson, A.; Weiss, E. S.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer
    Meeting Abstract

    Enzinger, P. C.; Burtness, B.; Hollis, D.; Niedzwiecki, D.; Ilson, D.; Benson, A. B.; Mayer, R. J.; Goldberg, R. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • A single-institution (MSKCC) analysis of incidence and clinical outcomes in patients with thromboembolic events and exocrine pancreas cancer
    Meeting Abstract

    Epstein, A. S.; Crosbie, C.; Gardos, S.; Soff, G. A.; Shah, M. A.; Kelsen, D. P.; O'Reilly, E. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Sunitinib (SU)-related hypertension in a randomized placebo (P)-controlled trial of GIST patients (pts)
    Meeting Abstract

    Ewer, M.; Suter, T. M.; Lenihan, D. J.; Niculescu, L.; Breazna, A.; Motzer, R. J.; Demetri, G. D.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Progression-free survival (PFS) as a new endpoint for designing phase II trials in patients with refractory germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save